The number of women who've been told 'it's just menopause' when something else was also going on — it's staggering. If your gut symptoms, bone density results, or fatigue feel out of proportion to what your friends describe, it's worth pushing for more answers. Celiac is one of the most underdiagnosed conditions in women over 40, and the overlap with menopause is a big reason why.
Learn more about Rose →Estrogen decline during perimenopause reduces bone density by slowing the activity of bone-building osteoblasts — a well-established mechanism that makes osteoporosis a central menopause concern. What's less widely known is that undiagnosed celiac disease causes the small intestine to malabsorb calcium and vitamin D, which independently drives bone loss regardless of hormone levels. A woman navigating both conditions simultaneously faces bone density decline from two separate physiological pathways, making her fracture risk significantly higher than standard menopause models predict.
Perimenopausal fatigue is driven largely by disrupted sleep, fluctuating progesterone, and the energy cost of hormonal dysregulation — all real and well-documented causes. Celiac disease adds iron-deficiency anemia and B12 malabsorption to that load, both of which cause profound, body-heavy exhaustion that sleep alone cannot resolve. Women who find that their fatigue is disproportionate, constant rather than cyclical, or accompanied by pallor or breathlessness have good reason to ask their clinician about nutrient malabsorption screening alongside standard hormone panels.
Estrogen fluctuations during perimenopause are directly linked to serotonin and GABA activity, which explains why anxiety, low mood, and emotional volatility are so common in the transition years. Celiac disease independently disrupts mood through intestinal inflammation, nutrient deficiencies — particularly folate, B12, and zinc — and the gut-brain axis, with emerging research linking gluten-related immune activation to neurological and psychiatric symptoms. Because both conditions affect mood through partially overlapping mechanisms, treating only the hormonal side rarely delivers full relief in someone who also has unmanaged celiac disease.
It is genuinely true that estrogen and progesterone influence gut motility, and that many women notice increased bloating, gas, and bowel irregularity during perimenopause — so clinicians are not wrong to make that connection. The problem is that these are also the defining symptoms of active celiac disease, where the immune response to gluten damages intestinal villi and disrupts normal digestion and absorption. When gut symptoms are assumed to be hormonal without ruling out celiac, a woman may spend years on symptom management rather than the one intervention — a gluten-free diet — that would actually address the source.
The cognitive blurring that many perimenopausal women describe — difficulty retrieving words, poor concentration, mental slowness — is linked to declining estrogen's effect on hippocampal function and neuroinflammation. Celiac disease produces its own neurological effects, including 'gluten ataxia' and what researchers have termed 'gluten encephalopathy,' driven by antibody cross-reactivity and systemic inflammation that can reach the brain. A woman dealing with both simultaneously may experience cognitive symptoms that feel far more disabling than typical menopause brain fog, and that do not improve with hormone therapy alone.
Celiac disease is not always present from childhood — it can remain clinically silent for years and become active in the context of a significant physiological stressor, including pregnancy, severe infection, or major hormonal shifts. There is growing clinical recognition that the immune system changes accompanying perimenopause may be sufficient to tip a genetically predisposed woman into active celiac disease for the first time, with symptoms emerging in her 40s or early 50s. This means a woman who never had digestive issues before may develop them during perimenopause and reasonably — but incorrectly — attribute them entirely to hormonal change.
Heavy or irregular periods in perimenopause are extremely common and are a legitimate cause of iron-deficiency anemia, so it makes clinical sense to investigate menstrual blood loss when a perimenopausal woman presents with low iron. What can be missed is that celiac disease also causes iron malabsorption in the proximal small intestine — the section most damaged by the celiac immune response — independent of any blood loss. When anemia persists after menstrual irregularity resolves or after iron supplementation, celiac disease should move up the differential diagnosis rather than being left uninvestigated.
Hashimoto's thyroiditis — an autoimmune thyroid condition — is significantly more prevalent in people with celiac disease, with studies suggesting shared immune pathways and molecular mimicry between gliadin proteins and thyroid tissue antigens. Thyroid dysfunction also becomes more common in women during and after menopause, partly due to immune system shifts in this life stage, creating a three-way overlap. Symptoms like fatigue, weight changes, mood shifts, and feeling cold — which belong to all three conditions — become nearly impossible to attribute correctly without comprehensive testing that includes both thyroid antibodies and celiac serology.
Oral hormone replacement therapy relies on absorption through the gastrointestinal tract, and the intestinal villous atrophy caused by active celiac disease can reduce the uptake of oral medications and supplements unpredictably. A woman who starts oral HRT and finds it is not delivering expected symptom relief — despite confirmed prescription and consistent use — may have an absorption problem rather than an inadequate dose. Transdermal HRT largely bypasses this issue since it is absorbed through the skin, which is one reason clinicians sometimes prefer it — but identifying the underlying celiac disease matters both for HRT effectiveness and for the many other health consequences of leaving it unmanaged.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.